Antonios Mikos, the Louis Calder Professor of Bioengineering and Chemical and Biomolecular Engineering at Rice University, has been elected to the European Academy of Sciences (EURASC), an international body that recognizes excellence in scientific research and technological innovation.
A global leader in biomaterials and tissue engineering, Mikos is widely known for his groundbreaking work in regenerative medicine, controlled drug delivery, gene therapy and disease modeling. His research has shaped the development of new biomaterials used in orthopedic, dental, cardiovascular, neurologic and ophthalmologic applications.
He will be formally inducted at the EURASC Annual Symposium and Ceremony Dec. 17-18 at CERN in Geneva.
“It’s an honor to join this distinguished community of scientists,” Mikos said. “The European Academy of Sciences stands for collaboration across borders and disciplines, and I look forward to contributing to its mission of advancing science for the benefit of society.”
Mikos directs Rice’s Biomaterials Lab, Center for Excellence in Tissue Engineering and J.W. Cox Laboratory for Biomedical Engineering. He is a member of the National Academy of Engineering, the National Academy of Medicine, the American Academy of Arts and Sciences, the Academia Europaea and the Academy of Athens, among many other honors.
He has authored more than 700 scientific publications, holds over 30 patents and is founding editor and editor-in-chief of the Tissue Engineering journals. A member of the Rice faculty since 1992, Mikos has mentored generations of researchers and helped shape the field of biomedical engineering worldwide.